2024 Publications
UCLA Division of Rheumatology Research
Our commitment to excellence extends beyond clinical practice, as we recognize the vital role of research in advancing the field of rheumatology and improving patient outcomes. Through rigorous investigation, our dedicated team of physicians and researchers seeks to uncover the underlying mechanisms of rheumatic conditions and develop targeted therapies tailored to each patient's unique needs.
Explore publications from our faculty and fellows below. Additional publications can be found by year in the menu to the left.
2024 Publications
-
Faghihi-Kashani S, Yoshida A, Bozan F, Zanframundo G, Rozza D, et al.
Faculty Contributor: Bae SS, Volkmann ER
Clinical Characteristics of Anti-Synthetase Syndrome: Analysis From the Classification Criteria for Anti-Synthetase Syndrome Project
Arthritis & Rheumatology, Epub 2024 Dec 17Volkmann ER
Understanding Late-Onset Interstitial Lung Disease in Systemic Sclerosis: Implications for Clinical Practice and Trial Design
Arthritis & Rheumatology, Epub 2024 Dec 1 -
Berg JI, Nielsen SM, Malm E, Ioannidis JPA, Furst DE, et al.
Faculty Contributor: Furst DE
Influence of Study Characteristics on Harm Estimates From Randomised Controlled Trials in Patients With Inflammatory Arthritis Receiving Biological or Synthetic Antirheumatic Drugs: A Meta-Epidemiological Study
Annals of Rheumatic Disease, 2024 Nov 8Channick J, Volkmann ER
Are We Ready for Home Spirometry for Systemic Sclerosis-Associated ILD?
The Lancet, Epub 2024 Nov 8Good SD, Adamus G, Gorin MB, Jacquez J, Grossman J, et al.
Faculty Contributors: Good SD, Jacquez J, Grossman J, Skaggs B, McMahon M
Anti-Retinal Autoantibodies in Hydroxychloroquine Eye Toxicity
ACR Open Rheumatology, Epub 2024 Nov 7 -
Good SD, Lee JY, Johnson RE, Volkmann ER
A Scoping Review of the Epidemiology of Systemic Sclerosis and Its Organ Manifestations: 2018–2024
Current Opinion in Rheumatology, Epub 2024 Oct 23Zhang W, Huang G, Zheng S, Lin J, Hu S, et al.
Faculty Contributor: Furst DE
Risk Prediction Modelling in Idiopathic Inflammatory Myositis-Associated Interstitial Lung Disease Based on Seven Factors Including Serum KL-6 and Lung Ultrasound B-Lines
Clinald and Experimental Rheumatology, Epub 2024 Oct 2 -
Wang Y, Chen S, Zheng S, Zhou Z, Zhang W, et al.
Faculty Contributor: Furst DE
A Versatile Role for Lung Ultrasound in Systemic Autoimmune Rheumatic Diseases Related Pulmonary Involvement: A Narrative Review
Arthritis Research and Therapy, 2024 Sep 18Kumar S, Ramaraju K, Kakarla MS, Eranezhath SS, Chenthamarakshan C, et al.
Faculty Contributor: Furst DE
Evaluating Personalized Add-On Ayurveda Therapy in Oxygen-Dependent Diabetic COVID-19 Patients: A 60-Day Study of Symptoms, Inflammation, and Radiological Changes
Cureus, 2024 Sep 1 -
Chen S, Fan Y, Wu Q, Zhang G, Wang Y, et al.
Faculty Contributor: Furst DE
Integrative Transcriptomic Analysis of Peripheral Blood Monocytes in Systemic Sclerosis and Shared Pathogenic Pathways in Autoimmune Diseases
Archives of Medical Research, Epub 2024 Aug 28Coccia C, Bonomi F, Lo Cricchio A, Russo E, Peretti S, et al.
Faculty Contributor: Furst DE
The Potential Role of Butyrate in the Pathogenesis and Treatment of Autoimmune Rheumatic Diseases
Biomedicines, 2024 Aug 5 -
Fleischmann R, Meerwein S, Charles-Schoeman C, Combe B, Hall S, et al.
Faculty Contributor: Charles-Schoeman C
Efficacy and Safety of Upadacitinib in Patients with Rheumatoid Arthritis and Inadequate Response or Intolerance to Biological Treatments: Results Through 5 Years from the SELECT-BEYOND Study
RMD Open, 2024Kuchinad KE, Kim JS, Woods A, Leatherman G, Gutierrez-Alamillo L, et al.
Faculty Contributor: Kafaja S
Racial Variability in Immune Responses Only Partially Explains Differential Systemic Sclerosis Disease Severity
Annals of Rheumatic Disease, 2024Alba MA, Kermani TA, Unizony S, Murgia G, Prieto-González S, et al.
Faculty Contributor: Kermani TA
Relapses in Giant Cell Arteritis: Updated Review for Clinical Practice
Autoimmunity Reviews, 2024Paik JJ, Vencovský J, Charles-Schoeman C, Wright GC, Vleugels RA, et al.
Faculty Contributor: Charles-Schoeman C
Brepocitinib, a Potent and Selective TYK2/JAK1 Inhibitor: Scientific and Clinical Rationale for Dermatomyositis
Clinical & Experimental Rheumatology, 2024 -
Pappas DA, Reed G, Kane K, Curtis JR, Charles-Schoeman C, et al.
Faculty Contributor: Charles-Schoeman C
Effect of Biologic Agents and Inflammation on Lipid Levels and Cardiovascular Risk in Rheumatoid Arthritis Patients
Seminars in Arthritis and Rheumatism, 2024Volkmann ER, Denton CP, Kolb M, Wijsenbeek-Lourens MS, Emson C, et al.
Faculty Contributor: Volkmann ER
Lysophosphatidic Acid Receptor 1 Inhibition: A Potential Treatment Target for Pulmonary Fibrosis
European Respiratory Review, 2024Kermani TA, Sreih AG, Cuthbertson D, Khalidi NA, Koening CL, et al.
Faculty Contributor: Kermani TA
Vasculitis Clinical Research Consortium. Assessment of Damage in Takayasu's Arteritis.
Rheumatology, 2024 -
Gagarine M, Cañedo-Ayala M, Cook V, Discepola MN, Guillot G, et al.
Faculty Contributor: Furst DE
Oral Health in Systemic Sclerosis: A Scoping Review
Journal of Scleroderma and Related Disorders, 2024 May 24Volkmann ER, Tashkin DP
Enrichment Strategies for Systemic Sclerosis-Interstitial Lung Disease Trials
American Journal of Respiratory and Critical Care Medicine, 2024Luo Y, Gordon JK, Xu J, Kolstad KD, Chung L, et al.
Faculty Contributor: Kolstad KD
Prognostic significance of pericardial effusion in systemic sclerosis-associated pulmonary hypertension: analysis from the PHAROS Registry
Rheumatology, 2024 -
Wareing N, Wang X, Keyes-Elstein L, Goldmuntz EA, Lyons MA, et al.
Faculty Contributor: Furst DE
Myeloablation Followed by Hematopoietic Stem Cell Transplantation and Long-Term Normalization of Systemic Sclerosis Molecular Signatures
Arthritis & Rheumatology, Epub 2024 Apr 29Buch MH, Bhatt DL, Charles-Schoeman C, Giles JT, Mikuls T, et al.
Faculty Contributor: Charles-Schoeman C
Risk of Extended Major Adverse Cardiovascular Event Endpoints with Tofacitinib Versus TNF Inhibitors in Patients with Rheumatoid Arthritis: A Post Hoc Analysis of a Phase 3B/4 Randomised Safety Study
RMD Open, 2024Andréasson K, Olofsson T, Lagishetty V, Alrawi Z, Klaassens E, et al.
Faculty Contributor: Volkmann ER
Treatment for Rheumatoid Arthritis Associated With Alterations in the Gastrointestinal Microbiota
ACR Open Rheumatology, 2024Lee JY, Reichl A, O'Brien C, Ayoub M
A Diagnostic Paradox: Identifying IgG4-Related Disease in a Patient Previously Diagnosed with Sjogren's Syndrome
Journal of Brown Hospital Medicine, 2024 Apr 1 -
Chung SA, Kermani TA
Improving on Intuition: Assessing Disease Activity in Takayasu Arteritis
Arthritis Care & Research, 2024El Aoufy K, Melis MR, Iovino P, Bambi S, Lorini C, et al.
Faculty Contributor: Furst DE
The Rising Challenge of Poor Health Literacy of Patients with Systemic Sclerosis: Preliminary Data Identify Important Unmet Needs in an Italian Cohort
Nursing Reports, 2024Horisberger A, Griffith A, Keegan J, Arazi A, Pulford J, et al.
Faculty Contributors: McMahon MA, Grossman J
Blood Immunophenotyping Identifies Distinct Kidney Histopathology and Outcomes in Patients with Lupus Nephritis
bioRxiv, 2024Yokose C, McCormick N, Abhishek A, Dalbeth N, Pascart T, et al.
Faculty Contributor: FitzGerald J
The Clinical Benefits of Sodium-Glucose Cotransporter Type 2 Inhibitors in People with Gout
Nature Reviews Rheumatology, 2024Charles-Schoeman C, Fleischmann R, Mysler E, Greenwald M, Ytterberg SR, et al.
Faculty Contributor: Charles-Schoeman C
Risk of Venous Thromboembolism With Tofacitinib Versus Tumor Necrosis Factor Inhibitors in Cardiovascular Risk-Enriched Rheumatoid Arthritis Patients
Arthritis & Rheumatology, 2024Benzon HT, Elmofty D, Shankar H, Rana M, Chadwick AL, et al.
Faculty Contributor: FitzGerald JD
Use of Corticosteroids for Adult Chronic Pain Interventions: Sympathetic and Peripheral Nerve Blocks, Trigger Point Injections - Guidelines from the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, the American Society of Interventional Pain Physicians, the International Pain and Spine Intervention Society, and the North American Spine Society
Regional Anesthesia & Pain Medicine, 2024Wareing N, Wang X, Keyes-Elstein L, Goldmuntz EA, Lyons MA, et al.
Faculty Contributor: Furst DE
Myeloablation Followed by Hematopoietic Stem Cell Transplantation Leads to Long-Term Normalization of Systemic Sclerosis Molecular Signatures
Arthritis & Rheumatology, 2024Szekanecz Z, Buch MH, Charles-Schoeman C, Galloway J, Karpouzas GA, et al.
Faculty Contributor: Charles-Schoeman C
Publisher Correction: Efficacy and Safety of JAK Inhibitors in Rheumatoid Arthritis: Update for the Practising Clinician
Nature Reviews Rheumatology, 2024El Aoufy K, Melis MR, Iovino P, Bambi S, Lorini C, et al.
Faculty Contributor: Furst DE
The Rising Challenge of Poor Health Literacy of Patients with Systemic Sclerosis: Preliminary Data Identify Important Unmet Needs in an Italian Cohort
Nursing Reports, 2024 Mar 5 -
Yen EY, Singh DR, Singh RR
Steady Decrease in Systemic Sclerosis Mortality Rates at Younger Ages Over the Past Five Decades
Rheumatology, 2024Ghuman A, Khanna D, Lin CJF, Furst DE, Raghu G, et al.
Faculty Contributor: Furst DE
Prognostic and Predictive Markers of Systemic Sclerosis-Associated Interstitial Lung Disease in a Clinical Trial and Long-Term Observational Cohort
Rheumatology, 2024Elfishawi MM, Kaymakci MS, Achenbach SJ, Crowson CS, Kermani TA, et al.
Faculty Contributor: Kermani TA
Reappraisal of Large Artery Involvement in Giant Cell Arteritis: A Population-Based Cohort Over 70 Years
RMD Open, 2024Mannion ML, Xie F, FitzGerald JD, Alexander A, Mudano A, et al.
Faculty Contributor: FitzGerald JD
Changes in the Workforce Characteristics of Providers Who Care for Adult Patients With Rheumatologic and Musculoskeletal Disease in the United States
Arthritis & Rheumatology, 2024Moroncini G, Svegliati S, Grieco A, Cuccioloni M, Mozzicafreddo M, et al.
Faculty Contributor: La Cava A
Adeno-Associated Virus Type 5 Infection via PDGFRα Is Associated With Interstitial Lung Disease in Systemic Sclerosis and Generates Composite Peptides and Epitopes Recognized by the Agonistic Immunoglobulins Present in Patients With Systemic Sclerosis
Arthritis & Rheumatology. 2024 -
Mease PJ, Reddy S, Ross S, Lisse JR, Reis P, et al.
Faculty Contributor: Furst DE
Evaluating the Efficacy of Biologics With and Without Methotrexate in the Treatment of Psoriatic Arthritis: A Network Meta-Analysis
RMD Open, 2024 Jan 31Lepri G, Bruni C, Tofani L, Moggi-Pignone A, Orlandi M, Tomassetti S, et al.
Faculty Contributor: Furst DE
The Performance of Pulmonary Function Tests in Predicting Systemic Sclerosis-Interstitial Lung Disease in the European Scleroderma Trial and Research Database
Diagnostics, 2024 Jan 30Charles-Schoeman C, Giles JT, Lane NE, Choy E, Furst DE, et al.
Faculty Contributors: Charles-Schoeman C, Furst DE
Impact of Upadacitinib on Laboratory Parameters and Related Adverse Events in Patients with RA: Integrated Data Up to 6.5 Years
Rheumatology and Therapy, 2024Szekanecz Z, Buch MH, Charles-Schoeman C, Galloway J, Karpouzas GA, et al.
Faculty Contributor: Charles-Schoeman C
Efficacy and Safety of JAK Inhibitors in Rheumatoid Arthritis: Update for the Practising Clinician
Nature Reviews Rheumatology, 2024Aggarwal R, Schessl J, Charles-Schoeman C, Bata-Csörgő Z, Dimachkie MM, Griger Z, et al.
Faculty Contributor: Charles-Schoeman C
Safety and tolerability of intravenous immunoglobulin in patients with active dermatomyositis: results from the randomised, placebo-controlled ProDERM study
Arthritis Research & Therapy, 2024Vassileva MT, Suresh V, Chan AC, Akinsete AV, Blanco I, et al.
Faculty Contributor: FitzGerald J
Improving Health Equity in Rheumatology Through Workforce Diversification and Support for Health Equity Research and Education.
Arthritis & Rheumatology, 2024Lepri G, Bruni C, Tofani L, Moggi-Pignone A, Orlandi M, et al.
Faculty Contributor: Furst DE
The Performance of Pulmonary Function Tests in Predicting Systemic Sclerosis-Interstitial Lung Disease in the European Scleroderma Trial and Research Database
Diagnostics, 2024Foeldvari I, Torok KS, Antón J, Blakley M, Constantin T, Cet al.
Faculty Contributor: Furst DE
Best Clinical Practice in the Treatment of Juvenile Systemic Sclerosis: Expert Panel Guidance – the Result of the International Hamburg Consensus Meeting December 2022
Expert Review of Clinical Immunology. Epub 2024 Jan 2Mease PJ, Reddy S, Ross S, Lisse JR, Reis P, et al.
Faculty Contributor: Furst DE
Evaluating the Efficacy of Biologics With and Without Methotrexate in the Treatment of Psoriatic Arthritis: A Network Meta-Analysis
RMD Open, 2024Hossain T, Montesi SB, Volkmann ER, Thomson CC, Ruminjo JK, et al.
Faculty Contributor: Volkmann ER
Summary for Clinicians-Clinical Practice Guideline for the Treatment of Systemic Sclerosis-associated Interstitial Lung Disease: Evidence-based Recommendations.
Annals of the American Thoracic Society, 2024